BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26108365)

  • 1. Metabolic syndrome is associated with left ventricular dilatation in primary hypertension.
    Ratto E; Viazzi F; Verzola D; Bonino B; Gonnella A; Parodi EL; Bezante GP; Leoncini G; Pontremoli R
    J Hum Hypertens; 2016 Mar; 30(3):158-63. PubMed ID: 26108365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular dilatation and subclinical renal damage in primary hypertension.
    Ratto E; Viazzi F; Bonino B; Gonnella A; Garneri D; Parodi EL; Bezante GP; Derchi LE; Leoncini G; Pontremoli R
    J Hypertens; 2015 Mar; 33(3):605-11; discussion 611. PubMed ID: 25426568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
    Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
    Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi D; Parodi A; Falqui V; Tomolillo C; Deferrari G; Pontremoli R
    J Intern Med; 2005 May; 257(5):454-60. PubMed ID: 15836662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between left ventricular deformation and different geometric patterns according to the updated classification: findings from the hypertensive population.
    Tadic M; Cuspidi C; Majstorovic A; Kocijancic V; Celic V
    J Hypertens; 2015 Sep; 33(9):1954-61; discussion 1961. PubMed ID: 26002842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women.
    Schillaci G; Pirro M; Pucci G; Mannarino MR; Gemelli F; Siepi D; Vaudo G; Mannarino E
    Hypertension; 2006 May; 47(5):881-6. PubMed ID: 16585414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients.
    Tadic M; Cuspidi C; Vukomanovic V; Kocijancic V; Celic V
    Arch Cardiovasc Dis; 2016 May; 109(5):311-20. PubMed ID: 27020514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects.
    Tsioufis C; Stefanadis C; Toutouza M; Kallikazaros I; Toutouzas K; Tousoulis D; Pitsavos C; Papademetriou V; Toutouzas P
    J Hum Hypertens; 2002 Apr; 16(4):249-54. PubMed ID: 11967718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study.
    Khouri MG; Peshock RM; Ayers CR; de Lemos JA; Drazner MH
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):164-71. PubMed ID: 20061518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and biventricular hypertrophy in essential hypertension.
    Cuspidi C; Valerio C; Sala C; Negri F; Esposito A; Masaidi M; Giudici V; Zanchetti A; Mancia G
    J Hum Hypertens; 2009 Mar; 23(3):168-75. PubMed ID: 18800141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities.
    de Simone G; Izzo R; Aurigemma GP; De Marco M; Rozza F; Trimarco V; Stabile E; De Luca N; Trimarco B
    J Hypertens; 2015 Apr; 33(4):745-54; discussion 754. PubMed ID: 25915879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study.
    Dobrowolski P; Prejbisz A; Klisiewicz A; Florczak E; Rybicka J; Januszewicz A; Hoffman P
    Hypertens Res; 2015 Aug; 38(8):545-50. PubMed ID: 25787038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of left ventricular geometry on left atrial phasic function in hypertensive patients.
    Tadic M; Cuspidi C; Pencic B; Kocijancic V; Celic V
    Blood Press; 2015; 24(6):361-8. PubMed ID: 26212876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
    Gerdts E; Cramariuc D; de Simone G; Wachtell K; Dahlöf B; Devereux RB
    Eur J Echocardiogr; 2008 Nov; 9(6):809-15. PubMed ID: 18490279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.